Cargando…
Risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Diabetes
Objectives: Diabetic kidney disease (DKD) is an independent predictor of cardiovascular morbidity and mortality in type 1 diabetes (T1D). We aimed to explore clinical and biochemical factors, including the achievement of American Diabetes Association (ADA) recommended targets associated with DKD in...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566893/ https://www.ncbi.nlm.nih.gov/pubmed/31162987 http://dx.doi.org/10.1080/0886022X.2019.1614057 |
_version_ | 1783426951692681216 |
---|---|
author | Sekercioglu, Nigar Lovblom, Leif Erik Bjornstad, Petter Lovshin, Julie A. Lytvyn, Yuliya Boulet, Geneviève Farooqi, Mohammed A. Orszag, Andrej Lai, Vesta Tse, Josephine Cham, Leslie Keenan, Hillary A. Brent, Michael H. Paul, Narinder Bril, Vera Perkins, Bruce A. Cherney, David Z. I. |
author_facet | Sekercioglu, Nigar Lovblom, Leif Erik Bjornstad, Petter Lovshin, Julie A. Lytvyn, Yuliya Boulet, Geneviève Farooqi, Mohammed A. Orszag, Andrej Lai, Vesta Tse, Josephine Cham, Leslie Keenan, Hillary A. Brent, Michael H. Paul, Narinder Bril, Vera Perkins, Bruce A. Cherney, David Z. I. |
author_sort | Sekercioglu, Nigar |
collection | PubMed |
description | Objectives: Diabetic kidney disease (DKD) is an independent predictor of cardiovascular morbidity and mortality in type 1 diabetes (T1D). We aimed to explore clinical and biochemical factors, including the achievement of American Diabetes Association (ADA) recommended targets associated with DKD in people living with T1D for ≥50 years. Methods: This was a post hoc analysis of a cross-sectional study of 75 participants enrolled in the Canadian Study of Longevity in T1D. We explored diabetes-related complications, including neuropathy, retinopathy, cardiovascular disease, and DKD. Study participants were dichotomized based on the achievement of ADA recommended targets as the low-target group (achieving ≤4 targets, n = 31) and high-target group (achieving >4 targets, n = 44). The outcome of interest was DKD defined by estimated glomerular filtration rate (eGFR) values <60/mL/min/1.73 m(2) and/or 24-h albumin excretion >30 mg. Multivariable logistic regression models were employed to estimate odds ratios (ORs) for DKD with 95% confidence intervals (CIs). Results: Of the 75 participants with prolonged T1D duration (45% male, mean age 66 years), 25 participants had DKD and 50 did not. There was no statistical difference between the high- and low-target groups in terms of age and body mass index. eGFR was significantly higher and the prevalence of diabetic retinopathy was significantly lower in the high-target group. Older age at diagnosis of T1D and lower frequency component to high-frequency component ratio increased the odds of having DKD. Conclusions: In adults with prolonged T1D duration, older age at diagnosis and lower heart rate variability may be associated with DKD. |
format | Online Article Text |
id | pubmed-6566893 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-65668932019-06-21 Risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Diabetes Sekercioglu, Nigar Lovblom, Leif Erik Bjornstad, Petter Lovshin, Julie A. Lytvyn, Yuliya Boulet, Geneviève Farooqi, Mohammed A. Orszag, Andrej Lai, Vesta Tse, Josephine Cham, Leslie Keenan, Hillary A. Brent, Michael H. Paul, Narinder Bril, Vera Perkins, Bruce A. Cherney, David Z. I. Ren Fail Clinical Study Objectives: Diabetic kidney disease (DKD) is an independent predictor of cardiovascular morbidity and mortality in type 1 diabetes (T1D). We aimed to explore clinical and biochemical factors, including the achievement of American Diabetes Association (ADA) recommended targets associated with DKD in people living with T1D for ≥50 years. Methods: This was a post hoc analysis of a cross-sectional study of 75 participants enrolled in the Canadian Study of Longevity in T1D. We explored diabetes-related complications, including neuropathy, retinopathy, cardiovascular disease, and DKD. Study participants were dichotomized based on the achievement of ADA recommended targets as the low-target group (achieving ≤4 targets, n = 31) and high-target group (achieving >4 targets, n = 44). The outcome of interest was DKD defined by estimated glomerular filtration rate (eGFR) values <60/mL/min/1.73 m(2) and/or 24-h albumin excretion >30 mg. Multivariable logistic regression models were employed to estimate odds ratios (ORs) for DKD with 95% confidence intervals (CIs). Results: Of the 75 participants with prolonged T1D duration (45% male, mean age 66 years), 25 participants had DKD and 50 did not. There was no statistical difference between the high- and low-target groups in terms of age and body mass index. eGFR was significantly higher and the prevalence of diabetic retinopathy was significantly lower in the high-target group. Older age at diagnosis of T1D and lower frequency component to high-frequency component ratio increased the odds of having DKD. Conclusions: In adults with prolonged T1D duration, older age at diagnosis and lower heart rate variability may be associated with DKD. Taylor & Francis 2019-06-04 /pmc/articles/PMC6566893/ /pubmed/31162987 http://dx.doi.org/10.1080/0886022X.2019.1614057 Text en © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Sekercioglu, Nigar Lovblom, Leif Erik Bjornstad, Petter Lovshin, Julie A. Lytvyn, Yuliya Boulet, Geneviève Farooqi, Mohammed A. Orszag, Andrej Lai, Vesta Tse, Josephine Cham, Leslie Keenan, Hillary A. Brent, Michael H. Paul, Narinder Bril, Vera Perkins, Bruce A. Cherney, David Z. I. Risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Diabetes |
title | Risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Diabetes |
title_full | Risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Diabetes |
title_fullStr | Risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Diabetes |
title_full_unstemmed | Risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Diabetes |
title_short | Risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Diabetes |
title_sort | risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the canadian study of longevity in diabetes |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566893/ https://www.ncbi.nlm.nih.gov/pubmed/31162987 http://dx.doi.org/10.1080/0886022X.2019.1614057 |
work_keys_str_mv | AT sekercioglunigar riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes AT lovblomleiferik riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes AT bjornstadpetter riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes AT lovshinjuliea riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes AT lytvynyuliya riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes AT bouletgenevieve riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes AT farooqimohammeda riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes AT orszagandrej riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes AT laivesta riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes AT tsejosephine riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes AT chamleslie riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes AT keenanhillarya riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes AT brentmichaelh riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes AT paulnarinder riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes AT brilvera riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes AT perkinsbrucea riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes AT cherneydavidzi riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes |